Welcome to WellRxCare. We provides Health medical accessories

Retevmo Selpercatinib 80mg 120 Capsules

Original price was: $1,080.00.Current price is: $800.00.

Retevmo (selpercatinib) is an oral kinase inhibitor that may be used to treat the following cancers caused by abnormal RET (rearranged during transfection) genes:

  • locally advanced non-small cell lung cancer (NSCLC) or NSCLC that has spread in adults
  • advanced or metastatic thyroid cancer in adults and children aged 2 years of age and older who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate)
  • advanced medullary thyroid cancer (MTC) or MTC that has spread and requires a medicine that treats the whole body (systemic therapy) in adults and children aged 2 years and older.

In Stock

-
+
Add to Wishlist
Add to Wishlist

Description

Retevmo is also approved under the accelerated approval designation for adults and children aged 2 years and older with locally advanced solid tumors (cancers) or solid tumors associated with abnormal RET genes that have spread or gotten worse (progressed) after other treatments, or who have no satisfactory alternative treatment options.

Retevmo side effects

The most common side effects of Retevmo include:

  • swelling of your arms, legs, hands, and feet (edema)
  • diarrhea
  • tiredness
  • dry mouth
  • high blood pressure
  • stomach-area (abdominal) pain
  • constipation
  • rash
  • nausea
  • headache.

The most common severe abnormal laboratory test results with Retevmo include decreased white blood cell count, decreased levels of sodium in the blood, and decreased levels of calcium in the blood.

Retevmo may affect fertility in females and males, which may affect your ability to have children. Talk to your healthcare provider if this is a concern for you.

Serious side effects

Retevmo may cause serious side effects, including:

  • Liver problems. Liver problems (increased liver enzymes) are common with Retevmo and may sometimes be serious. Your healthcare provider will do blood tests before and during treatment to check for liver problems. Tell your healthcare provider right away if you get any of the following symptoms of liver problems during treatment:
    • yellowing of your skin or the white part of your eyes (jaundice)
    • dark “tea-colored” urine
    • sleepiness
    • bleeding or bruising
    • loss of appetite
    • nausea or vomiting
    • pain on the upper right side of your stomach area
  • Lung problems. Retevmo may cause severe or life-threatening inflammation of the lungs during treatment, that can lead to death. Tell your healthcare provider right away if you have any new or worsening lung symptoms, including:
    • shortness of breath
    • cough
    • fever
  • High blood pressure (hypertension). High blood pressure is common with Retevmo and may sometimes be serious. You should check your blood pressure regularly during treatment. Tell your healthcare provider if you get any of the following symptoms:
    • confusion
    • headaches
    • shortness of breath
    • dizziness
    • chest pain
  • Heart rhythm changes (QT prolongation) can occur and may be serious. Retevmo may cause very slow, very fast or irregular heartbeats. Tell your healthcare provider right away if you get any of the following symptoms:
    • loss of consciousness
    • fainting
    • dizziness
    • a change in the way your heart beats (heart palpitations)
  • Bleeding problems. Retevmo can cause bleeding which can be serious and may lead to death. Tell your healthcare provider if you have any signs of bleeding during treatment, including:
    • vomiting blood or if your vomit looks like coffee-grounds
    • pink or brown urine
    • red or black (looks like tar) stools
    • coughing up blood or blood clots
    • unusual bleeding or bruising of your skin
    • menstrual bleeding that is heavier than normal
    • unusual vaginal bleeding
    • nose bleeds that happen often
    • drowsiness or difficulty being awakened
    • confusion
    • headache
    • change in speech
  • Allergic reactions. Retevmo can cause a fever, rash, muscle or joint pain, especially in the first month of treatment. Tell your healthcare provider if you get any of these symptoms.
  • Tumor lysis syndrome (TLS). TLS is caused by a fast breakdown of cancer cells. TLS can cause kidney failure, the need for dialysis treatment, and an abnormal heartbeat. TLS can lead to hospitalization. Your healthcare provider may do blood tests to check you for TLS. You should stay well hydrated during treatment with Retevmo. Call your healthcare provider or get emergency medical help right away if you develop any of these symptoms during treatment with Retevmo:
    • nausea
    • shortness of breath
    • vomiting
    • muscle cramps
    • weakness
    • seizures
    • swelling
  • Risk of wound healing problems. Wounds may not heal properly during treatment with Retevmo. Tell your healthcare provider if you plan to have any surgery before or during treatment with Retevmo.
    • Stop taking Retevmo at least 7 days before planned surgery.
    • Your healthcare provider should tell you when you may start taking Retevmo again after surgery.

Reviews

There are no reviews yet.

Be the first to review “Retevmo Selpercatinib 80mg 120 Capsules”

Your email address will not be published. Required fields are marked *

This error message is only visible to WordPress admins

Error: No feed found.

Please go to the Instagram Feed settings page to create a feed.